Bionano reports inducement grant under nasdaq listing rule 5635(c)(4)

San diego, sept. 22, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced that on september 18, 2023, the compensation committee of the company's board of directors (the “compensation committee”) granted an inducement award consisting of a non-qualified stock option to purchase 106,000 shares of common stock to gÜlsen kama, the company's new chief financial officer, under the company's 2020 inducement plan, as amended. the compensation committee approved the award as an inducement material to the new employee's employment in accordance with nasdaq listing rule 5635(c)(4).
BNGO Ratings Summary
BNGO Quant Ranking